Meet Dr. Yasir Elamin Video Jul 9 Written By Dave Bjork From the halls of ASCOI sat down with Dr. Yasir Elamin to get his thoughts on his presentation at ASCO regarding patient reported outcomes and health-related quality of life with Taletrectinib in advanced ROS1 non-small cell lung cancer (NSCLC) from the TRUST-II Study. Dave BjorkResearch Evangelistpodcastoncologylung cancerVideo PodcastVideo2026ASCOAmerican Society of Clinical OncologyMD Anderson Cancer CenterDr Yasir ElaminTRUST-II Study Dave Bjork
Meet Dr. Yasir Elamin Video Jul 9 Written By Dave Bjork From the halls of ASCOI sat down with Dr. Yasir Elamin to get his thoughts on his presentation at ASCO regarding patient reported outcomes and health-related quality of life with Taletrectinib in advanced ROS1 non-small cell lung cancer (NSCLC) from the TRUST-II Study. Dave BjorkResearch Evangelistpodcastoncologylung cancerVideo PodcastVideo2026ASCOAmerican Society of Clinical OncologyMD Anderson Cancer CenterDr Yasir ElaminTRUST-II Study Dave Bjork
